Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I7QX
|
|||
Former ID |
DNC007383
|
|||
Drug Name |
(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone
|
|||
Synonyms |
CHEMBL226183; (benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone; BDBM50202215; (Benzofuran-2-yl)(1H-indole-2-yl) ketone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H11NO2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=CC=CC=C4O3
|
|||
InChI |
1S/C17H11NO2/c19-17(14-9-11-5-1-3-7-13(11)18-14)16-10-12-6-2-4-8-15(12)20-16/h1-10,18H
|
|||
InChIKey |
NWBGABGOSKEFQJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorg Med Chem. 2007 Mar 1;15(5):2187-97. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.